Introduction
Many enveloped viruses including paramyxoviruses and human immunodeficiency virus (HIV) induce syncytia. Syncytium formation is one of the major cytopathic effects of virus-infected cells, and virus infection from cell-to-cell occurs without the production of infectious virus particles. In paramyxoviruses, two kinds of virus glycoproteins, haemagglutinin-neuraminidase (HN) and fusion (F), participate in cell fusion in virus-infected cells. However, cell fusion regulatory mechanisms in host cells are not well understood. We previously reported that anti-L *#* cell antiserum enhanced syncytium formation in Newcastle disease virus (NDV)-infected L *#* cells and suggested that factor(s) are present on the cell surface of host cells capable of regulating virusmediated cell fusion (Ito et al., 1987) . We have isolated Author for correspondence : Yasuhiko Ito.
Fax j81 592 31 5008. e-mail ito!doc.medic.mie-u.ac.jp fusion in HPIV-2-infected HeLa cells. Anti-FRP-1 MAbs including HBJ127 showed no effect on virus growth and expression levels of virus-specific polypeptides in HPIV-2-infected HeLa cells, indicating that the delay in cell fusion by an anti-FRP-1 MAb is not due to suppression of virus replication. When HeLa cells were transfected with an expression vector harbouring HPIV-2 HN and F genes, cell fusion was also suppressed by HBJ127, but the effect was weak in comparison with virus-infected cells. These data indicate anti-FRP-1 antibodies not only induce/enhance, but also inhibit/delay virusinduced cell fusion and therefore FRP-1 molecules are multifunctional. monoclonal antibodies (MAbs) which enhance cell fusion in NDV-infected HeLa cells (Ito et al., 1992) . These MAbs recognized gp80 and gp135 on the surface of HeLa cells. These molecules were considered to have the capability of regulating NDV-induced cell fusion and thus were designated fusion regulatory protein (FRP)-1 (gp80) and FRP-2 (gp135). The U2ME-7 cell line is a CD4 + U937 cell line transfected with the HIV gp160 gene ; the expression of gp160 is induced by cadmium chloride. Even after induction of HIV gp160, U2ME-7 cells did not form syncytia (Koga et al., 1990) . Anti-FRP-1 MAb or anti-FRP-2 MAb induced polykaryocyte formation in Cd + U2ME-7 cells (U2ME-7 cells treated with cadmium chloride) (Ohta et al., 1994) . FRP-1 was expressed selectively on monocytes. Anti-FRP-1 MAbs induced cell aggregation and multinucleated giant cell formation in monocytes (Tabata et al., 1994) . Moreover, induction of HIV-mediated cell fusion or cell aggregation and polykaryocyte formation of monocytes by anti-FRP-1 MAb was found to be related to the integrin system (Ohta et al., 1994 ; Tabata et al., 1994) . FRP-1 and FRP-2 were identified as the 4F2\CD98 heavy chain and the α3 subunit of integrin, respectively, by immunological, amino acid sequencing and gene cloning methods (Ohta et al., 1994 ; Ohgimoto et al., 1995) .
Anti-FRP-1 MAbs enhanced virus-mediated cell fusion and induced fusion of monocytes, but no anti-FRP-1 MAb was found to show inhibition\delay of cell fusion. In this study, we investigated whether anti-FRP-1 MAbs could enhance cell fusion in human parainfluenza virus type 2 (HPIV-2)-infected HeLa cells, as they do in NDV-infected HeLa cells. However, cell fusion in HPIV-2-infected HeLa cells was delayed when cells were incubated with HBJ127, an anti-FRP-1 MAb that enhanced cell fusion in NDV-infected HeLa cells. There were no anti-FRP-1 MAbs that enhanced cell fusion in HPIV-2-infected HeLa cells. We showed that inhibition of cell fusion by the anti-FRP-1 MAb was not due to low replication of HPIV-2. These results indicate that FRP-1 molecules have multiple functions in the cell fusion process.
Methods
Cells and viruses. HeLa and Vero cells were used in this study. The cells were cultured in Eagle's MEM supplemented with 5 % foetal calf serum. The viruses used in this study were the HPIV-2 Toshiba strain and the NDV Sato strain.
MAbs. Seven anti-FRP-1\CD98\4F2 MAbs were used. Anti-FRP-1 MAbs [4-5-1 (IgG1) and 6-1-13 (IgG1)] were previously described (Ito et al., 1992) . Anti-CD98\4F2 MAbs HBJ127 (IgG1), 4F2 (IgG1) and H227 (IgG1) were kindly supplied by Y. Hashimoto (Touhoku University, Sendai, Japan), B. F. Haynes (Duke University, Durham, N.C., USA) and M. Nakao (Kurume University, Kurume, Japan), respectively. Anti-FRP-1 MAbs 38-2-2 (IgG2a) and 18-1-2 were newly made in our laboratory. Anti-HPIV-4a NP MAb (IgG1) was used as control antibody.
Plaque assay. HeLa cells infected with HPIV-2 were incubated at 37 mC with or without each anti-FRP-1 MAb and culture fluid was harvested at 12 h to 24 h post-infection (p.i.). The 10-fold diluted culture fluids were added to Vero cells on 12-well plates, incubated for 1 h at 37 mC and overlaid with MEM containing 0n6 % SEA KEM agarose. Plaques were visualized after 3 days of incubation at 37 mC by staining with neutral red.
ELISA. HeLa cells, cultured in 96-well plates, were fixed with 3 % paraformaldehyde for 20 min. They were permeabilized with PBS and Tween-20 for 20 min to detect the cytoplasmic virus NP protein. Then they were incubated with various mouse IgG2a MAbs against HPIV-2 (HN, F or NP) for 1 h and reacted with peroxidase-conjugated anti-mouse IgG2a rat serum.
Flow cytometry. HeLa cells were incubated with anti-HPIV-2 HN (108S1, IgG2a) or F (119-1A, IgG2a) MAbs (Tsurudome et al., 1989) at 4 mC for 1 h and washed twice with PBS. Subsequently, the cells were reacted with fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG2a rat MAb (Serotec) at 4 mC for 30 min and washed twice. Immunofluorescence-stained cells were analysed on a FACScan (Becton Dickinson).
Induction of cell fusion in HeLa cells by transfection with recombinant plasmids containing HN and F genes. The expression vector pcDL-SRα296 containing HPIV-2 HN and F gene cDNAs (pSR-HN, pSR-F) was used as described previously (Yuasa et al., 1995) . pcDL-SRα296 is a plasmid vector developed for expressing proteins in eukaryotic cells. It contains a poly(A) signal and two promoters, the SV40 early promoter and the R-U5 sequence of the HTLV-1 LTR (Takebe et al., 1988) . The pSR-HN and pSR-F vectors were transfected into HeLa cells by the calcium phosphate method using a kit (CellPhect ; Pharmacia) and cell fusion was induced 24 h post-transfection as reported previously (Yuasa et al., 1995 ; Tsurudome et al., 1995) .
Results

Inhibition of HPIV-2-induced cell fusion and enhancement of NDV-induced cell fusion by MAb HBJ127
HeLa cells (approximately 10& cells per well in a 96-multiwell dish) were infected with NDV at an m.o.i. of 1. The cells were incubated with MEM supplemented with 5 % foetal calf serum and each anti-FRP-1\CD98\4F2 MAb (total seven MAbs, 5 µg\ml) was added to the culture fluid at the same time. At 15 h p.i., the cells were stained with Giemsa and observed by microscopy. The addition of anti-FRP-1\CD98 MAbs 4-5-1, 6-1-13 and HBJ127 to the culture fluids of NDVinfected HeLa cells gave rise to giant polykaryocytes, while only slight cell fusion was observed in the presence of the other three MAbs (Table 1) 
Control antibody
* Polykaryocytosis : k, 3%; j, 3-25 % ; jj, 25-50 % ; jjj, 50-75 % ; jjjj, 75-100 %. † Giemsa-stained at 15 h p.i. ‡ Giemsa-stained at 18 h p.i.
HPIV-2-induced cell fusion and FRP-1 HPIV-2-induced cell fusion and FRP-1 infected HeLa cells was suppressed by MAb HBJ127, which enhanced polykaryocyte formation in NDV-infected HeLa cells (Table 1 ; Fig. 1 ). Another six anti-FRP-1 MAbs showed neither enhancing nor suppressing effects on cell fusion in HPIV-2-infected HeLa cells.
Kinetics of polykaryocyte formation in HPIV-2-infected HeLa cells in the presence of anti-FRP-1 MAbs
A kinetic study of polykaryocyte formation in HPIV-2-infected HeLa cells was carried out (Fig. 2) . HeLa cells were infected with HPIV-2 and incubated in MEM containing 5 % foetal calf serum with MAb 4-5-1, HBJ127, 38-2-2 or control antibody. At appropriate times, the cells were stained with Giemsa and examined for morphological alterations including cell fusion. At 12 h p.i., multinucleated giant cells were observed in the presence of control antibody, MAb 38-2-2 and 4-5-1, but never in the presence of HBJ127. Almost all cells formed syncytia in the presence of control antibody at 18 h p.i. On the other hand, in the presence of HBJ127, little fusion was seen until 18 h p.i. ; almost all cells formed polykaryocytes by 24 h p.i. In short, polykaryocyte formation in HPIV-2-infected HeLa cells was delayed by the addition of the anti-FRP-1\CD98 MAb HBJ127. Anti-FRP-1 MAbs 38-2-2 and 4-5-1 showed no effect on cell fusion of HPIV-2-infected HeLa cells. HBJ127 on virus-specific polypeptide expression, but to a secondary effect via cellular factor(s) modified by stimulation of the FRP-1 molecule.
Expression of HN and F proteins on the cell surface of HPIV-2-infected HeLa cells in the presence of anti-FRP-1 MAbs
Virus-induced cell fusion is mediated by interaction between virus glycoproteins and host proteins on the cell surface. One of the possible mechanisms by which cell fusion of HPIV-2-infected HeLa cells was suppressed by anti-FRP-1 MAb is suppression of HN and\or F protein expression on the cell surface. Thus, the effect of anti-FRP-1 MAbs on expression of HN and F proteins was investigated. HeLa cells were infected with HPIV-2 and then incubated with MAb 4-5-1, HBJ127, 6-1-13 or control antibody at 37 mC. At 18 h p.i., the cells were suspended in PBS and incubated with anti-HPIV-2 HN or F MAb. The cells were reacted with FITC-conjugated anti-mouse IgG2a rat MAb and immunofluorescence-stained cells were analysed on a FACScan. As shown in Fig. 5 , there was little difference between the effect of anti-FRP-1 MAbs and control antibody on the expression of HN and F proteins at the cell surface. Therefore, the inhibition of cell fusion of HPIV-2-infected cells by HBJ127 is not due to low expression of HN and\or F proteins on the cell surface. Also, there was little difference in the expression of NP protein between HPIV-2-infected HeLa cells treated with anti-FRP-1 MAbs and control antibody (data not shown).
Effects of anti-FRP-1 MAbs on cell fusion in HeLa cells co-expressing HN and F proteins
HPIV-2 HN and F proteins were expressed in HeLa cells using the expression vector pcDL-SRα296 containing cDNAs encoding each protein (pSR-HN or pSR-F), which was constructed from cDNA fragments previously prepared for nucleotide sequencing of the glycoprotein genes (Kawano et al., 1990 a, b) . When HeLa cells were transfected with either pSR-HN or pSR-F, cell fusion was not observed. Cell fusion similar to that in virus-infected cells was seen when HeLa cells were cotransfected with pSR-HN and pSR-F (Yuasa et al., K. Okamoto and others K. Okamoto and others (a) (b) Fig. 6 . Effect of HBJ127 on cell fusion in HeLa cells co-expressing HPIV-2 HN and F proteins after transfection with recombinant plasmids. HeLa cells on 24-well plates were incubated with MEM plus 10 % foetal calf serum. Then 0n2 µg of HPIV-2 pSR-HN and -F were added to HeLa cells by the calcium phosphate method. After 4 h of incubation at 37 mC, cells were treated with 15 % glycerol in HEPES-buffered saline (50 mM HEPES, 0n75 mM sodium phosphate, 140 mM NaCl) at room temperature for 3 min, and incubated in MEM plus 10 % foetal calf serum at 37 mC with control antibody (a) or an anti-FRP-1 MAb HBJ127 (b). After 20 h incubation, the cells were stained with Giemsa staining solution and observed under a microscope.
1995). Consequently, the effects of MAb HBJ127, 4-5-1 and 6-1-13 on cell fusion in both HN and F protein-expressing HeLa cells were investigated. A decrease in fused cells was observed in the presence of HBJ127 (Fig. 6) , while there was no difference in polykaryocyte formation in the presence of MAb 4-5-1, 6-1-13 and control antibody (data not shown). This result is consistent with that of HPIV-2-infected HeLa cells. However, the level of suppression of cell fusion by HBJ127 was lower with the expression system than with virus infection. Indeed, a fivefold higher concentration of HBJ127 was required to show a suppressive effect on cell fusion in the HN and F expressing cells compared with virus-infected cells.
Discussion
FRP-1\4F2\CD98 is a cell surface protein, which is expressed in all established cells derived from humans and monkeys (Teixeira et al., 1987 ; Tabata et al., 1994) . We have recently reported that FRP-1 and the 4F2\CD98 heavy chain are identical molecules (Ohgimoto et al., 1995) . However, the function of the 4F2\CD98 molecule is not well understood. Our previous reports showed that (i) anti-FRP-1 MAbs enhanced cell fusion in NDV-infected cells (Ito et al., 1992 ; Ohgimoto et al., 1995) ; (ii) anti-FRP-1 MAbs induced HIV gp160-mediated cell fusion (Ohta et al., 1994 ; Ohgimoto et al., 1995) ; and (iii) anti-FRP-1 MAbs induced homotypic cell aggregation and cell fusion of peripheral blood monocytes (Tabata et al., 1994) . In this work, we reported that an anti-FRP-1 MAb, HBJ127, delayed cell fusion in HPIV-2-infected HeLa cells. HBJ127 is one of the anti-FRP-1\4F2\CD98 MAbs that enhanced cell fusion in NDV-infected HeLa cells and induced HIV gp160-mediated cell fusion. However, another six anti-FRP-1 MAbs showed neither enhancing nor suppressing effects on cell fusion in HPIV-2-infected HeLa cells. Thus, FRP-1 molecules showed opposite reactions in cell fusion between HPIV-2-infected cells and NDV-infected cells, although both viruses belong to the same genus Rubulavirus.
We examined the effects of anti-FRP-1 MAbs including HBJ127 on virus growth and expression levels of virus-specific polypeptides in HPIV-2-infected HeLa cells, in order to determine the mechanism by which HBJ127 delayed HPIV-2-induced cell fusion. HBJ127 and other anti-FRP-1 MAbs had little effect on virus growth in HPIV-2-infected HeLa cells or the expression levels of virus glycoproteins and NP protein in these cells. These results indicate that the delay in cell fusion in HPIV-2-infected cells by HBJ127 is not due to a direct effect of HBJ127 on HPIV-2 replication, but to a secondary effect via cellular factor(s) modified by the stimulated FRP-1 molecule.
Both HN and F glycoproteins on the cell surface are required for cell fusion of paramyxoviruses (Ebata et al., 1991 ; Morrison et al., 1991 ; Hu et al., 1992) . Neither HBJ127, 4-5-1 nor 6-1-13 had any influence on the expression of the virus glycoproteins HN and F in HPIV-2-infected HeLa cells. HBJ127 also suppressed cell fusion in HeLa cells that transiently coexpressed HPIV-2 HN and F glycoproteins. These results indicate that FRP-1 interferes little with the virus life cycle in HPIV-2-infected HeLa cells. The time-course of virus growth and expression of virus-specific polypeptides, and expression of HN and F proteins on the cell surface, were not influenced by HBJ127, as found with the other anti-FRP-1 MAbs.
As previously reported (Ohgimoto et al., 1995) , L929 cells constitutively expressing human FRP-1\CD98 (L929\CD98H cells) were established. When L929\CD98H cells were infected with NDV, cell fusion was not induced in the absence of anti-FRP-1 MAb. When NDV-infected L929\CD98H cells were incubated in the presence of anti-FRP-1 MAbs 4-5-1 or HBJ127, multinucleated giant cells were induced (Ohgimoto et al., 1995 ; unpublished data) . Thus, it was concluded that anti-FRP-1 MAbs activate the FRP-1 molecule, which can transduce the cell fusion-enhancing signal into NDV-infected cells.
HPIV-2-induced cell fusion and FRP-1 HPIV-2-induced cell fusion and FRP-1 Expression of human FRP-1\4F2\CD98 cDNA in murine L *#* cells made the cells susceptible to the cell fusionactivating activity of anti-FRP-1 MAb on infection with NDV. There was no anti-FRP-1 MAb that showed suppression\ inhibition of cell fusion. Hence, it was not clear whether FRP-1 had only inducing\enhancing activity on membrane fusion. The present work indicates that FRP-1 molecules transduce a cell fusion-suppressing signal into HPIV-2-infected cells, indicating that stimulation of FRP-1 molecules transduces not only a cell fusion-enhancing signal but also a suppressing signal. However, it is not clear at present why FRP-1 molecules have opposite effects on membrane fusion in HPIV-2-infected cells and NDV-infected cells, though they belong to the same genus.
In a HPIV-2 glycoprotein expression system the effect of anti-FRP-1 MAbs was the same as in HPIV-2-infected cells ; that is, cell fusion of HeLa cells transiently co-expressing HPIV-2 HN and F proteins was suppressed by HBJ127. However, the effect on the glycoprotein expression system was weaker than that on the virus infection system. We constructed recombinant pcDL-SRα296 plasmids encoding either the HN protein or the F protein of NDV. When the HN and F proteins were co-expressed in HeLa cells, cell fusion was observed (unpublished data). In this NDV expression system, however, there was no difference in cell fusion without or with the anti-FRP-1 MAbs HBJ127, 4-5-1 or 6-1-13 that had markedly enhanced cell fusion in NDV-infected HeLa cells. One possibility is that another virus-specific protein(s) (for example, the M protein) might participate in the fusion regulatory system via the FRP-1 molecule in paramyxovirusinfected cells.
In conclusion, one (HBJ127) of the anti-FRP-1 MAbs delayed cell fusion induced by HPIV-2. Virus growth, synthesis of virus-specific polypeptides and expression of virus glycoproteins on the cell surface were not suppressed by anti-FRP MAb. HBJ127 had an opposite effect on cell fusion in HPIV-2-infected cells compared to NDV-infected cells, although they belonged to the same genus Rubulavirus. The present data indicate that FRP-1 regulates virus-induced cell fusion and may enhance\induce or suppress\inhibit cell fusion depending on the virus-cell system.
